Apnea Clinical Trial - High Flow Nasal Oxygen Therapy Undergoing

Status Not yet recruiting

Clinical Trial Summary

Investigation of the Clinical Efficacy of High Flow Nasal Oxygen in Patients Over 60 Years of Age Undergoing Colonoscopy

Clinical Trial Description

70 patients who underwent colonoscopy under elective conditions will be included in the study. Routine monitoring will be applied to the patients in the outpatient room in accordance with the standard protocol and the findings in the preoperative period will be recorded. The dose and frequency of anesthesia applied in the routine will not be interfered with and the recorded data will be collected by an observer other than the practitioner. Randomization between groups will be achieved by taking the patients on the surgical procedure list sequentially. For both groups, after positioning the patients and placing the cannulas, preoxygenation will be performed for 5 minutes before induction of anesthesia. Oxygenation will be carried out at 35°C and 50 lt/min flow rate from the High Flow Nasal Cannula device, with inspired oxygen fraction equivalent to 40% in both groups, 5 lt/min in Group N, and inspired oxygen fraction equivalent to 40% in Group H, and immediately Anesthesia induction will then be applied.Oxygen saturation and other hemodynamic data of the patients in the room air before preoxygenation,oxygen saturation and hemodynamic data before induction after preoxygenation, oxygen saturation and hemodynamic data every minute during the procedure,oxygen saturation and hemodynamic data at the end of the procedure will be recorded. Interventions for respiratory safety, such as chin thrust, painful stimulus, inspired oxygen fraction increase, airway placement and mask ventilation, in case of apnea (stopping breathing for 10 seconds or more) or oxygen saturation ≤92% that may occur after induction until the end of the procedure , drug applications and other undesirable events will be recorded. As a result of the study, High Flow Nasal Cannula and low flow nasal cannula, which is the standard conventional method, will be compared in terms of desaturation and hypoxemia in my colonoscopy procedures performed under sedation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05396274
Study type	Interventional
Source	Turkish Society of Anesthesiology and Reanimation
Contact	UTKU SAGLAM, 1
Phone	905079701310
Email	utkusaglam23@gmail.com
Status	Not yet recruiting
Phase	N/A
Start date	May 26, 2022
Completion date	December 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04498598` - Structural Modification In Supraglottic Airway Device	N/A
Completed	`NCT05532670` - N600X Low Saturation Accuracy Validation
Enrolling by invitation	`NCT04106401` - Intravascular Volumes in Hypoxia During Antarctic Confinement	N/A
Recruiting	`NCT05883137` - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Not yet recruiting	`NCT05817448` - Hypoxia-induced Autophagy in the Pathogenesis of MAP
Recruiting	`NCT02661152` - DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.	Phase 3
Terminated	`NCT02801162` - Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard	N/A
Not yet recruiting	`NCT02201875` - Intrinsic Periodic Pattern of Breathing	N/A
Completed	`NCT02943863` - Regional Ventilation During High Flow Nasal Cannula and Conventional Nasal Cannula in Patients With Hypoxia	N/A
Completed	`NCT02105298` - Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study)	N/A
Completed	`NCT01922401` - Inverse Ratio Ventilation on Bariatric Operation	N/A
Active, not recruiting	`NCT01681238` - Goal-directed Therapy in High-risk Surgery	N/A
Completed	`NCT01463527` - Using Capnography to Reduce Hypoxia During Pediatric Sedation	N/A
Completed	`NCT01507623` - Value of Capnography During Nurse Administered Propofol Sedation (NAPS)	N/A
Withdrawn	`NCT00638040` - The Gene Expression Studies of the Role of Tumor Microenvironments in Tumor Progression	N/A
Active, not recruiting	`NCT06097754` - Intermittent Exogenous Ketosis (IEK) at High Altitude	N/A
Completed	`NCT04589923` - The VISION-Acute Study
Completed	`NCT05044585` - Evaluation of RDS MultiSense® in Desaturation Analysis in Healthy Volunteers	N/A
Completed	`NCT03659513` - The Effect of ECMO on the Pharmacokinetics of the Drugs and Their Clinical Efficacy
Completed	`NCT03221387` - Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

High Flow Nasal Oxygen Therapy Undergoing Colonoscopy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms